1. Home
  2. Analysis
  3. Nascobal
  4. Heparin

Nascobal and Heparin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nascobal (cyanocobalamin) and Heparin (heparin sodium). Common drug interactions include headache among females and blood magnesium decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Nascobal and Heparin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Nascobal?

Nascobal has active ingredients of cyanocobalamin. eHealthMe is studying from 462 Nascobal users. Check the latest studies of Nascobal.

What is Heparin?

Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.

On Jul, 11, 2026

14 people who take Nascobal and Heparin together, and have interactions are studied.

Nascobal and Heparin drug interactions.

What are the common drug interactions of Nascobal and Heparin, by gender? *:

female:

  1. Headache (pain in head)
  2. Infusion related reaction
  3. Asthenia (weakness)
  4. Back pain
  5. Fatigue (feeling of tiredness)
  6. Injury
  7. Myalgia (muscle pain)
  8. Blood magnesium decreased
  9. Pruritus (severe itching of the skin)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

male:

  1. Blood magnesium decreased
  2. Faecal incontinence (a lack of control over passing stool)
  3. Intestinal obstruction
  4. Device related infection
  5. Gastric infection (infection of stomach)
  6. Gastrointestinal infection (infection of stomach and intestine)
  7. Gastrointestinal stoma complication (complication of an opening surgically made in digestive tract)
  8. Hospitalisation
  9. Poor venous access
  10. Respiratory disorder (respiratory disease)

What are the common drug interactions of Nascobal and Heparin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Pruritus (severe itching of the skin)
  2. Urticaria (rash of round, red welts on the skin that itch intensely)

60+:

  1. Blood magnesium decreased
  2. Faecal incontinence (a lack of control over passing stool)
  3. Gastric infection (infection of stomach)
  4. Gastrointestinal infection (infection of stomach and intestine)
  5. Gastrointestinal stoma complication (complication of an opening surgically made in digestive tract)
  6. Hospitalisation
  7. Intestinal obstruction
  8. Poor venous access

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 9 people, 64.29%
  2. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 5 people, 35.71%

* Approximation only. Some reports may have incomplete information.

Do you take Nascobal and Heparin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nascobal and Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nascobal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nascobal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Heparin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyanocobalamin and heparin sodium (the active ingredients of Nascobal and Heparin, respectively), and Nascobal and Heparin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.